The foray into this new segment will help Vimta to enter into the growing CDMO business of biologics and peptides
Padmanabhan brings over two decades of extensive experience in FMCG sector
Asahi Kasei Life Science covers a broad range of bioprocess products and services
Sumitomo Chemical began its nucleic acid drug substance contract manufacturing business in 2013
L-HPC was independently developed by Shin-Etsu Chemical as a disintegrant for tablets
Amaran Biotech boasts Taiwan’s first fully automated robotic aseptic filling line, offering high-quality and low-waste filling solutions for high-value pharmaceuticals
Prior to joining Eris, Ranganathan was Commercial Director, Women's Health, Metabolics, and International Business at Abbott India Limited
The recent EU approval of MBL's plant has opened new avenues to explore such opportunities
The acquisition aligns with Granules' vision to enter the rapidly expanding peptide-based anti-diabetic and anti-obesity market
Subscribe To Our Newsletter & Stay Updated
